A detailed history of Anson Funds Management LP transactions in Liquidia Corp stock. As of the latest transaction made, Anson Funds Management LP holds 176,403 shares of LQDA stock, worth $1.88 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
176,403
Previous 176,403 -0.0%
Holding current value
$1.88 Million
Previous $1.76 Million -0.0%
% of portfolio
0.21%
Previous 0.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.9 - $14.11 $1.57 Million - $2.49 Million
176,403 New
176,403 $1.76 Million
Q1 2021

May 14, 2021

SELL
$2.42 - $3.6 $322,026 - $479,048
-133,069 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$2.6 - $5.79 $345,979 - $770,469
133,069 New
133,069 $393,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $685M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.